Bromantane and cellular immune responses in experimental models
T. S. Galushina, T. A. Fadeeva, N. G. Artsimovich · 1996 · Immunologiya. 1996;(4):28–30.
Reported findings and study design
Narrative findings; numerical extraction incomplete
In vivo and in vitro cellular immune assays. The abstract does not provide arm sizes or dose.
| Measure | Result | Comparison, timing and statistics |
|---|---|---|
| Delayed skin hypersensitivity and lymph node response | Increased | Separate cellular immune assays |
| T-cell precursor maturation | Increased | |
| Immune changes in NZB mice | Partial prevention reported |
Source for these results ↗ · Reviewed 2026-11-10
For research and education. Consult a qualified clinician for medical advice.
Study limitations and source details
Study limitations
- The accessible abstract gives no dose, group sizes or effect magnitudes.
Source access
Original article abstract available. Full methods and numerical tables require the complete article.
Source reviewed 2026-11-10.
Citation and original source
Original source: T. S. Galushina, T. A. Fadeeva, N. G. Artsimovich. Bromantane and cellular immune responses in experimental models Immunologiya. 1996;(4):28–30. 1996.
Molekul research summary: https://molekul.io/research/bromantane-galushina-cellular-immunity-1996. Cite the original publication for its findings and this page when referring to Molekul’s summary or evidence appraisal.
Bibliography entry